Clinical trials
Recruiting Phase 3 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 10 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 3 |
| Children's Oncology Group | 2 |
| Shanghai Jiao Tong University School of Medicine | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Chinese PLA General Hospital | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| Hutchmed | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 33 |
| Leukemia | 2 |
| Recurrence | 2 |
| Disease | 1 |
| Down Syndrome | 1 |
| Hematologic Neoplasms | 1 |
| Myelodysplastic Syndromes | 1 |
| Neoplasms | 1 |
| Pathologic Complete Response | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.